|
| |
Image Results
Loading...
Loading...
Gliobastoma AND Companies Pages on BioPortfolio:
|
BioPortfolio's Cancer Conditions News Feed
... search engine and services on biotechnology, pharmaceutical and healthcare research, companies and organizations, ... Glioblastoma · Glioma Subependymal
...
http://www.bioportfolio.co.uk/news/cancer_list.html...
|
BioPortfolio - MagForce Nanotechnologies AG - Profile
Currently, the technology is tested in clinical registration studies with glioblastoma and prostate cancer patients. Since September 2007 the company is
...
http://www.bioportfolio.com/biocorporate/35900-MagForce+Nano...
|
BioPortfolio's Rare Diseases News Feed
... pharmaceutical news, data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, companies and
organizations ...
http://www.bioportfolio.co.uk/news/rare.shtml...
|
BioPortfolio - Howard Hughes Medical Institute - Profile
7 Nov 2009 ... Glioblastoma multiforme remains one of the most intractable human...11th ... Growth Partnership Company, is pleased to announce that the ...
http://www.bioportfolio.com/biocorporate/24013-Howard+Hughes...
|
BioPortfolio.com - BioWeb Astrocytoma Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, ... Synonyms Anaplastic Astrocytoma Astrocytoma, grades 3-4 Giant Cell Glioblastoma,
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
Bio-Rad image competition attracts entries of outstanding quality ...
Bio-Rad was the first company to commercialise confocal and multi-photon ... A U87 glioblastoma tumour implanted in the brain of an immune deficient (SCID) ...
http://www.bioportfolio.com/news/biorad_2.htm...
|
BioPortfolio.com - BioWeb Germinoma Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, ... astrocytomas Anaplastic astrocytomas Glioblastoma multiforme Brain Stem ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
| Results from other life science and pharmaceutical sites:
Genentech: Newsroom: Press Releases: News Release May 5, 2009
5 May 2009 ... The efficacy of Avastin in glioblastoma that has progressed following .... Genentech is a leading biotechnology company that discovers, ...
http://www.gene.com/gene/news/press-releases/display.do?meth...
|
SuperGen, Inc. Granted Orphan Drug Designation for MP-470 in ...
7 Aug 2008 ... "Glioblastoma is the most common malignant primary brain tumor, ... the company's development strategy in pursuing areas of unmet need." ...
http://www.biospace.com/news_story.aspx?NewsEntityId=106085...
|
Genentech: Newsroom: Press Statements
9 Mar 2009 ... The company submitted the application for Avastin under the FDA's accelerated ... Glioblastoma is the most aggressive form of brain cancer, ...
http://www.gene.com/gene/news/press-releases/press_statement...
|
Bevacizumab Brings Optimism to Recurrent Glioblastoma
10 Sep 2009 ... Bevacizumab Brings Optimism to Recurrent Glioblastoma .... Dr. Friedman has acted as a consultant for the company and has received honoraria ...
http://www.medscape.com/viewarticle/708686...
|
Genentech: Newsroom: Press Releases: News Release November 3, 2008
3 Nov 2008 ... This is a devastating disease and people with glioblastoma desperately need new ... The company has headquarters in South San Francisco, ...
http://www.gene.com/gene/news/press-releases/display.do?meth...
|
MagForce Nanotechnologies Reaches Primary Study Endpoint in ...
3 Nov 2009 ... of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma. ... Visit other onTargetjobs companies ...
http://www.biospace.com/news_story.aspx?NewsEntityId=161593...
|
Genentech: Newsroom: Press Releases: News Release March 31, 2009
31 Mar 2009 ... Glioblastoma affects approximately 10000 people per year in the United ... Genentech is a leading biotechnology company that discovers, ...
http://www.gene.com/gene/news/press-releases/display.do?meth...
|
Bevacizumab Brings Optimism to Recurrent Glioblastoma
10 Sep 2009 ... Dr. Friedman has acted as a consultant for the company and has received ... AACR 2009: MRI Measure Predicts Glioblastoma Response to ...
http://www.medscape.com/viewarticle/708686?src=mpnews&spon=7...
|
Roche - FDA ADVISORY COMMITTEE UNANIMOUSLY RECOMMENDS ACCELERATED ...
1 Apr 2009 ... Glioblastoma affects approximately 10000 people per year in the United States ... As the world's biggest biotech company and an innovator of ...
http://www.roche.com/investors/ir_update/inv-update-2009-04-...
|
A question of focus : Article : Bioentrepreneur
Isn't it also true that by having a "three-point" business plan, BestBioCo is better able to manage risk: if the glioblastoma leads fail, the company could
...
http://www.nature.com/bioent/2003/030101/full/nbt0601supp_BE...
|
|
